Thursday, June 11, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1168 of 1,261
  1. US 6635765

    Processes for preparing torsemide intermediate

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Oct 21, 2003 Β· Expires Oct 16, 2023

    expired
  2. US 6635614

    Use of lecithin-cholesterol acyltransferase (LCAT) to reduce accumulation of cholesterol

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Oct 21, 2003 Β· Expires Oct 16, 2023

    expired
  3. US 6635644

    Inhibitors of p38

    Vertex Pharmaceuticals Incorporated Β· Granted Oct 21, 2003 Β· Expires Oct 16, 2023

    expired
  4. US 6635618

    Glycopeptide phosphonate derivatives

    Theravance, Inc. Β· Granted Oct 21, 2003 Β· Expires Oct 16, 2023

    expired
  5. US 6635672

    Agent for lowering prolactin

    Bionorica AG Β· Granted Oct 21, 2003 Β· Expires Oct 16, 2023

    expired
  6. US 6635445

    Nucleic acid molecules encoding human luteinizing hormone-human chorionic gonadotropin receptor protein and transformants thereof

    Takeda Chemical Industries Ltd. Β· Granted Oct 21, 2003 Β· Expires Oct 16, 2023

    expired
  7. CA 2477935

    PRODUITS DE SYNTHESE MULTIVALENTS POUR APPLICATIONS THERAPEUTIQUES ET DIAGNOSTIQUES

    BRACCO INT BV [NL] Β· Granted Oct 16, 2003 Β· Expires Oct 11, 2023

    expired
  8. US 2003194376

    Ultrasound contrast agents and methods of making and using them

    BRACCO INT BV [US] Β· Granted Oct 16, 2003 Β· Expires Oct 11, 2023

    expired
  9. US 6632962

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated Β· Granted Oct 14, 2003 Β· Expires Oct 9, 2023

    expired
  10. US 6632789

    Methods for modulating T cell responses by manipulating intracellular signal transduction

    United States of America as represented by the Secretary of the Air Force Β· Granted Oct 14, 2003 Β· Expires Oct 9, 2023

    expired
  11. US 6632945

    Inhibitors of P38

    Vertex Pharmaceuticals Incorporated Β· Granted Oct 14, 2003 Β· Expires Oct 9, 2023

    expired
  12. US 6632640

    Vaccine against Staphylococcus intoxication

    The United States of America as represented by the Secretary of the Army Β· Granted Oct 14, 2003 Β· Expires Oct 9, 2023

    expired
  13. US 6632446

    Coating substrates by polymerizing macromers having free radical-polymerizable substituents

    The Board of Regents of the University of Texas System Β· Granted Oct 14, 2003 Β· Expires Oct 9, 2023

    expired
  14. US 6632807

    (2R,4S)-(−)-[N-(4-diethoxyphosphorylmethyl)phenyl]-1,2,4,5- tetrahydro-4-methyl-7,8-methylenedioxy-5-oxo-3-benzothiepin-2-carboxamide

    Takeda Chemical Industries Ltd. Β· Granted Oct 14, 2003 Β· Expires Oct 9, 2023

    expired
  15. US 6632928

    Immunotoxins and methods of inducing immune tolerance

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Oct 14, 2003 Β· Expires Oct 9, 2023

    expired
  16. US 6632628

    Methods and compositions relating to HDAC 4 and 5 regulation of cardiac gene expression

    The Board of Regents of the University of Texas System Β· Granted Oct 14, 2003 Β· Expires Oct 9, 2023

    expired
  17. US 6632441

    Mutants of streptococcal toxin a and methods of use

    Regents of the University of Minnesota Β· Granted Oct 14, 2003 Β· Expires Oct 9, 2023

    expired
  18. US 6632437

    Immunogenic polysaccharide-protein conjugates containing poly &agr;(2→8), &agr;(2→9) NeuNAc capsular polysaccharides

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Oct 14, 2003 Β· Expires Oct 9, 2023

    expired
  19. US 6632434

    Leptospiral major outer membrane protein, LipL 32

    The Regents of the University of California Β· Granted Oct 14, 2003 Β· Expires Oct 9, 2023

    expired
  20. US 6632809

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated Β· Granted Oct 14, 2003 Β· Expires Oct 9, 2023

    expired
  21. US 6632808

    Inhibitors of amyloid formation

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Oct 14, 2003 Β· Expires Oct 9, 2023

    expired
  22. US 6632626

    Methods of assaying farnesyl transferase

    The Board of Regents of the University of Texas System Β· Granted Oct 14, 2003 Β· Expires Oct 9, 2023

    expired
  23. US 6632627

    Glutamine: fructose-6-phosphate amidotransferase, its production and use

    Takeda Chemical Industries Ltd. Β· Granted Oct 14, 2003 Β· Expires Oct 9, 2023

    expired
  24. AU 2003224729

    (+)-2-(1-(3-ETHOXY-4-METHOXYPHENYL)-2-METHYLSULFONYLETHYL)-4-ACETYLAMINOISOINDOLINE-1,3-DIONE: METHODS OF USING AND COMPOSITIONS THEREOF

    CELGENE CORP [CH] Β· Granted Oct 8, 2003 Β· Expires Oct 3, 2023

    expired

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.